Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control

Journal of Clinical Investigation

Volumn 113, Issue 9, 2004, Pages 1344-1352

  Karai, Laszlo ^a   Brown, Dorothy C ^b   Mannes, Andrew J ^a   Connelly, Stephen T ^a   Brown, Jacob ^a   Gandal, Michael ^a   Wellisch, Ofer M ^a   Neubert, John K ^a   Olah, Zoltan ^a   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CATION CHANNEL; ISOFLURANE; RESINIFERATOXIN; VANILLOID RECEPTOR 1; DITERPENE; DRUG RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CALCIUM CELL LEVEL; CANCER PAIN; CELL DISRUPTION; CONTROLLED STUDY; CYTOTOXICITY; DOG; HUMAN; HUMAN TISSUE; HYPERALGESIA; MALE; MUSCLE SPINDLE AFFERENT NERVE; NERVE ENDING; NEUROGENIC INFLAMMATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PERIKARYON; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SPINAL GANGLION; TRIGEMINUS GANGLION; ADULT; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CONTRAST MEDIUM EXTRAVASATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; METHODOLOGY; MICROINJECTION; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; SENSORY NERVE CELL; SPRAGUE DAWLEY RAT; STEREOTAXIC SURGERY; TIME;

ADULT; ANALGESIA; ANIMALS; CALCIUM; CELLS, CULTURED; DITERPENES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GANGLIA, SPINAL; HUMANS; MALE; MICROINJECTIONS; NEURONS, AFFERENT; NOCICEPTORS; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; STEREOTAXIC TECHNIQUES; TIME FACTORS; TRIGEMINAL GANGLION;

EID: 85047690839     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20449     Document Type: Article

References (58)

1. Bernabei, R., et al. 1998. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA. 279:1877-1882.
2. Cleeland, C.S., et al. 1994. Pain and its treatment in outpatients with metastatic cancer. N. Engl. J. Med. 330:592-596.
3. Wolfe, J., et al. 2000. Symptoms and suffering at the end of life in children with cancer. N. Engl. J. Med. 342:326-333.
4. Eddy, N.B., and May, E.L. 1973. The search for a better analgesic. Science. 181:407-414.
5. Nitu, A.N., Wallihan, R., Skljarevski, V., and Ramadan, N.M. 2003. Emerging trends in the pharmacotherapy of chronic pain. Expert Opin. Investig. Drugs. 12:545-559.
6. Scholz, J., and Woolf, C.J. 2002. Can we conquer pain? Nat. Neurosci. 5 (Suppl):1062-1067.
7. Cowan, J.D., and Walsh, D. 2001. Terminal sedation in palliative medicine-definition and review of the literature. Support Care Cancer. 9:403-407.
8. Cowan, J.D., and Palmer, T.W. 2002. Practical guide to palliative sedation. Curr. Oncol. Rep. 4:242-249.
9. Harrison, P. 2001. Update on pain management for advanced genitourinary cancer. J. Urol. 165:1849-1857; discussion 157-158.
10. Foley, K.M., and Gelband, H. 2001. Improving palliative care for cancer. National Academy Press, Washington DC, USA. 325 pp.
11. Smith, T.J., et al. 2002. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J. Clin. Oncol. 20:4040-4049.
12. Richardson, J.D., and Vasko, M.R. 2002. Cellular mechanisms of neurogenic inflammation. J. Pharmacol. Exp. Ther. 302:839-845.
13. Tominaga, M., et al. 1998. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:531-543.
14. Caterina, M.J., et al. 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 389:816-824.
15. Szallasi, A., and Blumberg, P.M. 1989. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience. 30:515-520.
16. Olah, Z., et al. 2001. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J. Biol. Chem. 276:11021-11030.
17. Jancso, N., Jancso-Gabor, A., and Szolcsanyi, J. 1967. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. 31:138-151.
18. Holzer, P. 1998. Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol. 30:5-11.
19. Bhave, G., et al. 2002. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron. 35:721-731.
20. 2+ in the desensitization responses to capsaicin, zingerone and olvanil in rat trigeminal ganglion neurons. Brain Res. 809:246-252.
21. Holzer, P. 1991. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43:143-201.
22. Price, T.J., Helesic, G., Parghi, D., Hargreaves, K.M., and Flores, C.M. 2003. The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience. 120:155-162.
23. Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:77-88.
24. Iadarola, M.J., Douglass, J., Civelli, O., and Naranjo, J.R. 1988. Differencial activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res. 455:205-212.
25. Davis, J.B., et al. 2000. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 405:183-187.
26. Caterina, M.J., et al. 2000. Impaired nociception and pain sensation in mice lacking the capsaicin receptor [see comments]. Science. 288:306-313.
27. Benoliel, R., et al. 1999. Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain. 79:243-253.
28. Zimmermann, M. 2001. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429:23-37.
29. Kauppila, T. 1998. Correlation between autotomy-behavior and current theories of neuropathic pain. Neurosci. Biobehav. Rev. 23:111-129.
30. Macrae, W.A. 2001. Chronic pain after surgery. Br. J. Anaesth. 87:88-98.
31. Neubert, J.K., et al. 2003. Peripherally induced resiniferatoxin analgesia. Pain. 104:219-228.
32. Graham, D.I., and Lantos, P.L. 1997. Greenfield's Neuropathology. 6th edition. Volume 2. Arnold. New York, New York, USA. Oxford University Press. London, United Kingdom. 395 pp.
33. Smart, D., et al. 2001. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol. 417:51-58.
34. Raymon, H.K., et al. 1999. Immortalized human dorsal root ganglion cells differentiate into neurons with nociceptive properties. J. Neurosci. 19:5420-5428.
35. Dionne, R.A., et al. 1998. The substance P receptor antagonist CP-99,994 reduces acute postoperative pain. Clin. Pharmacol. Ther. 64:562-568.
36. Jancso, G., and Kiraly, E. 1981. Sensory neurotoxins: chemically induced selective destruction of primary sensory neurons. Brain Res. 210:83-89.
37. Yaksh, T.L., Farb, D.H., Leeman, S.E., and Jessell, T.M. 1979. Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science. 206:481-483.
38. Nagy, J.I., Emson, P.C., and Iversen, L.L. 1981. A reevaluation of the neurochemical and antinociceptive effects of intrathecal capsaicin in the rat. Brain Res. 211:497-502.
39. Appendino, G., and Szallasi, A. 1997 Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci. 60:681-696.
40. Iadarola, M.J., et al. 1998. Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain. 121:931-947
41. Jeftinija, S., Liu, F., Jeftinija, K., and Urban, L. 1992. Effect of capsaicin and resiniferatoxin on peptidergic neurons in cultured dorsal root ganglion. Regul. Pept. 39:123-135.
42. Maggi, C.A., et al. 1990. Similarities and differences in the action of resiniferatoxin and capsaicin on central and peripheral endings of primary sensory neurons. Neuroscience. 37:531-539.
43. Sweet, W.H. 1984. Deafferentacion pain after posterior rhizocorny, trauma to a limb, and herpes zoster. Neurosurgery. 15:928-932.
44. Taha, J.M., and Tew, J.M., Jr. 1996. Comparison of surgical treatments for trigeminal neuralgia: reevaluation of radiofrequency rhizotomy. Neurosurgery. 38:865-871.
45. Traub, R.J., Iadarola, M.J., and Ruda, MA. 1989. Effect of multiple dorsal rhizotomies on calcitonin gene-related peptide-like immunoreactivity in the lumbosacral dorsal spinal cord of the cat: a radioimmunoassay analysis. Peptides. 10:979-983.
46. Woolf, C.J., Shortland, P., and Coggeshall, R.E. 1992. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature. 355:75-78.
47. Santha, P., and Jancso, G. 2003. Transganglionic transport of choleragenoid by capsaicin-sensitive C-fibre afferents to the substantia gelatinosa of the spinal dorsal horn after peripheral nerve section. Nettroscience. 116:621-627.
48. Bao, L., et al. 2002. Peripheral axotomy induces only very limited sprouting of coarse myelinated afferents into inner lamina II of rat spinal cord. Eur. J. Neurosci 16:175-185.
49. Pan, H.L., Khan, G.M., Alloway, K.D., and Chen, S.R. 2003. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J. Neurosci. 23:2911-2919.
50. Caudle, R.M., et al. 2003. Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells. Neurotoxicology. 24:895-908.
51. LaMotte, R.H., Lundberg, L.E., and Torebjork, H.E. 1992. Pain, hyperalgesia and activity in nociceptive C. units in humans after intradermal injection of capsaicin, J. Physiol. 448:749-764.
52. Nolano, M., et al. 1999. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 81:135-145.
53. Ferrell, W.R., Lam, F.Y., and Montgomery, I. 1992. Differences in the axon composition of nerves supplying the rat knee joint following intra-articular injection of capsaicin. Neurosci. Lett. 141:259-261.
54. Sasamura, T., Sasaki, M., Tohda, C., and Kuraishi, Y. 1998. Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. Neuroreport. 9:2045-2048.
55. Marinelli, S., Vaughan, C.W., Christie, M.J., and Connor, M. 2002. Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J. Physiol. 543:531-540.
56. Szabo, T., Biro, T., Gonzalez, A.F., Palkovits, M., and Blumberg, P.M. 2002. Pharmacological characterization of vanilloid receptor located in the brain. Brain Res. Mol. Brain Res. 98:51-57.
57. Mezey, E., et al. 2000. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U. S. A. 97:3655-3660.
58. Winter, J., Dray, A., Wood, J.N., Yeats, J.C., and Bevan. S. 1990. Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res. 520:131-140.